SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 75 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | -66.0% | 24,072 | -39.8% | 0.00% | -100.0% |
| Q2 2023 | $268 | -18.0% | 39,969 | -20.4% | 0.00% | 0.0% |
| Q1 2023 | $327 | -28.6% | 50,243 | -6.5% | 0.00% | -50.0% |
| Q4 2022 | $458 | -99.9% | 53,714 | -34.5% | 0.00% | 0.0% |
| Q3 2022 | $433,000 | +14.2% | 82,033 | -7.3% | 0.00% | 0.0% |
| Q2 2022 | $379,000 | +27.6% | 88,458 | +4.6% | 0.00% | +100.0% |
| Q1 2022 | $297,000 | -47.3% | 84,566 | -0.2% | 0.00% | -50.0% |
| Q4 2021 | $564,000 | +263.9% | 84,731 | +445.7% | 0.00% | +100.0% |
| Q3 2021 | $155,000 | -68.9% | 15,528 | -3.6% | 0.00% | -50.0% |
| Q2 2021 | $498,000 | -28.0% | 16,108 | +1.6% | 0.00% | -33.3% |
| Q1 2021 | $692,000 | +36.2% | 15,860 | +44.7% | 0.00% | +50.0% |
| Q4 2020 | $508,000 | – | 10,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $10,085,000 | 3.26% |
| K2 PRINCIPAL FUND, L.P. | 3,247,533 | $16,890,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,045,234 | $5,519,000 | 1.09% |
| Orbimed Advisors | 8,740,887 | $46,152,000 | 0.86% |
| Rubric Capital Management LP | 2,695,170 | $14,230,000 | 0.72% |
| Prosight Management, LP | 196,257 | $1,036,000 | 0.56% |
| Nantahala Capital Management | 1,249,863 | $6,599,000 | 0.43% |
| Oasis Management Co Ltd. | 317,662 | $1,677,000 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 409,463 | $2,162,000 | 0.26% |
| APOGEM CAPITAL LLC | 13,793 | $73,000 | 0.07% |